Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 0904-7359

9 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 0904-7359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lurasidone-structure (Lurasidone 1)

Lurasidone-structure (Lurasidone 1)
Chemical structure of lurasidone hydrochloride, showing its molecular layout with rings, bonds, and an HCl component.*
FDA Label Image

Lurasidone-fig2 (Lurasidone Fig2)

Lurasidone-fig2 (Lurasidone Fig2)
A chart titled Impact of other drugs on Lurasidone Pharmacokinetics (PK) showing fold changes and 90% confidence intervals for Cmax and AUC when lurasidone is co-administered with strong CYP3A4 inhibitors (ketoconazole 400 mg/day), moderate CYP3A4 inhibitors (diltiazem 240 mg/day), and strong CYP3A4 inducers (rifampin 600 mg/day and lithium 600 mg BID). The x-axis displays change relative to lurasidone alone ranging from -4 to 4 fold.*
FDA Label Image

Lurasidone-fig2 (Lurasidone Fig3)

Lurasidone-fig2 (Lurasidone Fig3)
A forest plot chart illustrating the pharmacokinetic interactions of lurasidone hydrochloride with various interacting drugs. It displays fold changes and 90% confidence intervals for parameters such as Cmax, AUC, and trough levels relative to the interacting drug alone, including drugs like Digoxin, Midazolam, oral contraceptives (Ethinyl Estradiol, Norelgestromin), and Lithium.*
FDA Label Image

Lurasidone-fig3 (Lurasidone Fig4)

Lurasidone-fig3 (Lurasidone Fig4)
A dot plot chart illustrating fold changes with 90% confidence intervals for pharmacokinetic parameters Cmax and AUC across different groups. The groups include varying degrees of renal impairment (mild, moderate, severe), hepatic impairment (mild, moderate, severe), and population descriptions by gender (females) and race (Asian). The x-axis represents change relative to reference, ranging from 0 to 6.*
FDA Label Image

20mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 04)

20mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 04)
Major Pharmaceuticals lurasidone hydrochloride 20 mg oral film-coated tablets unit dose packaging label. The label displays the NDC 0904-7355-04 and indicates a unit dose format with 30 tablets (3 x 10). It includes storage instructions, dispensing guidance, and a barcode. The label notes the product is prescription only and intended for institutional use.*
FDA Label Image

40mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 03)

40mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 03)
Lurasidone Hydrochloride 40 mg film-coated tablets unit dose packaging label by Major Pharmaceuticals. The package contains 100 tablets (10 x 10). The label includes storage instructions and a medication guide warning, specifying the product is Rx only and not child-resistant, intended for institutional use.*
FDA Label Image

60mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 02)

60mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 02)
This packaging label is for Lurasidone Hydrochloride 60 mg film-coated tablets, manufactured by Major Pharmaceuticals. It is a unit dose package containing 100 tablets (10 blister packs of 10 tablets each). The label includes storage instructions and a note that the product is prescription-only and intended for institutional use.*
FDA Label Image

80mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 01)

80mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 01)
Label for lurasidone hydrochloride 80 mg film-coated oral tablets by Major Pharmaceuticals. The unit dose packaging contains 100 tablets (10 x 10) with instructions for pharmacists to dispense with a medication guide. The label provides storage conditions, medication warnings, and states the product is for prescription use only.*
FDA Label Image

120mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 00)

120mg Carton Label (6e4065a5 2672 4ef4 996d F9d2f58970d3 00)
This label is for lurasidone hydrochloride 120 mg oral film-coated tablets by Major Pharmaceuticals. It specifies a unit dose packaging containing 30 tablets (3 blister cards of 10 tablets each). The label includes dosing instructions, storage conditions, and a notice that the package is for institutional use only and is not child resistant. It also provides manufacturer and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.